source
- Ionis veteran scientist Frank Bennett to retire in 2027 as Recursion appoints its first AI chiefIonis announced that Frank Bennett, who joined the company as a founding scientist in 1989 and later became chief scientific officer, will retire in February 2027 after a 37-year career. Bennett’s…
- Novo's IL-6 inhibitor fails in cardiovascular Phase 3, plunging shares more than 9%Novo Nordisk's IL-6 inhibitor ziltivekimab failed to reduce the risk of cardiovascular events in the late-stage trial, dashing hopes for an edge in the hyper-competitive cardiometabolic space.BioSpace · 3h ago↗ source
- Moderna maintains 10% growth target despite Phase 3 norovirus miss